You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Generics
Cipla launches generic liraglutide injection in the US
Login
Username:

Password:


Related Headlines

MS Pharma enters strategic partnership with Hetero Group

Apiject to open new generic injectable drug manufacturing facility in Apex, NC

Sun Pharma announces US availability of UNLOXCYT (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma

Bionpharma and STEERLife's Etravirine tablets approved by US FDA

ScinoPharm Taiwan secures first US FDA approval for complex multiple sclerosis generic

ScinoPharm Taiwan's Glatiramer Acetate Injection approved by US FDA

International Isotopes Inc to change name to Radnostix Inc

Accord Healthcare launches Clomiphene tablets in US market

Zentiva receives ESG Transparency Award 2025

Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin

Ingenus Pharmaceuticals' generic equivalent to Premarin receives US FDA approval

EirGenix signs second global exclusive licensing deal with Sandoz

Padagis invests USD36m to expand manufacturing in Minneapolis

Newbury Pharmaceuticals gains Danish approval for generic ivermectin cream

BioArctic and Eisai's Leqembi Iqlik (lecanemab-irmb) selected as one of TIME's best innovations of 2025

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026